Junctophilin-2 gene therapy rescues heart failure by normalizing RyR2-mediated Ca2+ release
- 1 December 2016
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 225, 371-380
Abstract
No abstract availableKeywords
Funding Information
- Mouse Phenotyping Core at Baylor College of Medicine (U54 HG006348)
This publication has 39 references indexed in Scilit:
- Alterations in ryanodine receptors and related proteins in heart failureBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- In Vivo Suppression of MicroRNA-24 Prevents the Transition Toward Decompensated Hypertrophy in Aortic-Constricted MiceCirculation Research, 2013
- Ryanodine Receptors: Structure and FunctionJournal of Biological Chemistry, 2012
- Subcellular Structures and Function of Myocytes Impaired During Heart Failure Are Restored by Cardiac Resynchronization TherapyCirculation Research, 2012
- Emerging role of junctophilin-2 as a regulator of calcium handling in the heartActa Pharmacologica Sinica, 2010
- Accelerated Development of Pressure Overload–Induced Cardiac Hypertrophy and Dysfunction in an RyR2-R176Q Knockin Mouse ModelHypertension, 2010
- 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in AdultsCirculation, 2009
- Adeno-Associated Virus (AAV) Serotype 9 Provides Global Cardiac Gene Transfer Superior to AAV1, AAV6, AAV7, and AAV8 in the Mouse and RatHuman Gene Therapy, 2008
- Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectorsCardiovascular Research, 2006
- Reduction in density of transverse tubules and L-type Ca2+ channels in canine tachycardia-induced heart failureCardiovascular Research, 2001